OTHER FUNCTIONS: TOPIC 287, PHASE II NANOTECHNOLOGY SENSING PLATFORMS

Information

  • Research Project
  • 8557600
  • ApplicationId
    8557600
  • Core Project Number
    N44CO000000
  • Full Project Number
    261201200043C-0-0-1
  • Serial Number
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/28/2012 - 12 years ago
  • Project End Date
    9/27/2014 - 10 years ago
  • Program Officer Name
  • Budget Start Date
    -
  • Budget End Date
    -
  • Fiscal Year
    2012
  • Support Year
  • Suffix
  • Award Notice Date
    -
Organizations

OTHER FUNCTIONS: TOPIC 287, PHASE II NANOTECHNOLOGY SENSING PLATFORMS

Label-free, highly sensitive early cancer detection sensors with required specificity are in great demand. In Phase 1, we experimentally confirmed feasibility of our proposed photonic crystal (PC) microarray with real data better than all reported sensing methods. These include absolute biomolecule mass sensitivity 8.8attograms (10A-18grams), surface mass sensitivity 0.8picogram (10A-12grams)/mmA2 in a sensing area 5.7micronA2. We demonstrated sensing capability of 72 binding reactions between a target and its conjugate probe biomolecule simultaneously, at the same time with 60 microliters total probe sample volume. We detected lung cancer ceillysates with specificity by sandwich assay. In Phase 2, all demonstrated components for chip integrated microarray will be integrated with antibodies detecting lung and breast cancer cell Iysates with high sensitivity, specificity and throughput via committed collaborations with Medical University of South Carolina and MD Anderson Cancer Center. The device has biomolecule functionalized PC microcavity resonator arrays coupled to a PC waveguide, further arrayed using multimode interference splitters, which transduce specific binding between probe and target biomolecules. Our multi-analyte sensing has applications in drug discovery, food feedstock assays and biD-warfare defense. Silicon CMOS compatibility ensures mass manufacturability with at least one order of magnitude better cost of ownership than any existing approach

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    N44
  • Administering IC
    CA
  • Application Type
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    1000000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:1000000\
  • Funding Mechanism
    SBIR/STTR Contracts
  • Study Section
  • Study Section Name
  • Organization Name
    OMEGA OPTICS, INC.
  • Organization Department
  • Organization DUNS
    102861262
  • Organization City
    AUSTIN
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    787596113
  • Organization District
    UNITED STATES